Highest-materiality recent filing
Colgate-Palmolive annual meeting: all 10 directors elected, say-on-pay approved
All 10 director nominees elected with votes for ranging from 580.9M to 630.7M.
Colgate Q1: net sales +8.4%, organic +2.9%; GAAP EPS $0.80 (-6%), base EPS $0.97 (+7%)
Net sales $5.324B (+8.4%), organic sales +2.9%; global toothpaste share 41.1% year-to-date.
Colgate-Palmolive names Betsy Fishbone as new Chief Legal Officer effective June 1, 2026
Jennifer M. Daniels, CLO & Secretary since 2014, plans to retire in 2026.
Colgate-Palmolive realigns segments effective Q1 2026; creates new EMEA segment
Europe and Africa/Eurasia (ex-Russia/Belarus) plus Skin Health from North America form new Europe, Middle East & Africa segment.
Colgate-Palmolive adds BMY CEO Boerner to board; director Cahillane to leave in May
Christopher S. Boerner (Bristol-Myers Squibb CEO) elected to Board, effective March 15, 2026.
Colgate-Palmolive FY2025 revenue +1.4% to $20.4B; GAAP EPS $2.63, down 25% on impairment
Full year net sales $20,382M (+1.4%); organic sales growth +1.4% after -0.7% impact from lower private label pet volume.
Colgate-Palmolive issues €600M 3.250% Senior Notes due 2035
€600 million aggregate principal amount of 3.250% Senior Notes due 2035 issued on November 10, 2025.
Colgate-Palmolive Q3 net sales up 2% to $5.13B, EPS $0.91; announces $200-300M restructuring program
Net sales $5.13B (+2% YoY); organic sales +0.4% reflecting exit of non-strategic pet business.
Colgate Q2 EPS $0.91, organic sales +1.8%; approves $200-300M productivity plan
Net sales $5,110M (+1.0%); organic sales +1.8% including -0.6% from lower private label pet sales.
Colgate-Palmolive appoints Shane Grant as COO Americas; Parameswaran retires
Shane Grant, former Danone Deputy CEO, appointed COO Americas from June 16, 2025.
the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.
the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.
The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
and John Hazlin to the position of Chief Growth Officer
has communicated to the Company her intention to retire from the Company on October 1, 2025.
Max materiality 0.75 · Median 0.53 · Most common event earnings